Monte Rosa Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC GLUE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

448,714

Value ($000)

7,036

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,036	0.0%	448,714	12/31/2025
2025 Q3	11/10/2025	2,840	0.0%	383,268	9/30/2025
2025 Q2	8/12/2025	1,720	0.0%	381,337	6/30/2025
2025 Q1	9/15/2025	1,678	0.0%	361,535	3/31/2025
2024 Q4	2/6/2025	2,571	0.0%	370,472	12/31/2024
2024 Q3	11/12/2024	1,836	0.0%	346,498	9/30/2024
2024 Q2	8/12/2024	1,166	0.0%	311,800	6/30/2024
2024 Q1	5/9/2024	1,767	0.0%	250,582	3/31/2024
2023 Q4	2/6/2024	1,387	0.0%	245,562	12/31/2023
2023 Q3	11/8/2023	1,162	0.0%	242,493	9/30/2023
2023 Q2	8/10/2023	1,577	0.0%	230,218	6/30/2023
2023 Q1	5/12/2023	1,748	0.0%	224,386	3/31/2023
2022 Q4	2/13/2023	1,708	0.0%	224,484	12/31/2022
2022 Q3	11/14/2022	1,742	0.0%	213,215	9/30/2022
2022 Q2	8/15/2022	1,124	0.0%	116,234	6/30/2022
2022 Q1	5/13/2022	1,759	0.0%	125,400	3/31/2022
2021 Q4	2/11/2022	1,737	0.0%	85,062	12/31/2021
2021 Q3	11/16/2021	1,782	0.0%	79,974	9/30/2021